Table 2.
KEGG Pathway Enrichments for Proteins Associated with Platinum Response in Ovarian Serous Carcinoma
| ID | term | number of genes | corrected P-value |
|---|---|---|---|
| 4978 | mineral absorption | 4 | 4.88 × 10−04 |
| 190 | oxidative phosphorylation | 5 | 4.88 × 10−04 |
| 5012 | Parkinson’s disease | 5 | 4.88 × 10−04 |
| 3013 | RNA transport | 5 | 4.88 × 10−04 |
| 4520 | adherens junction | 4 | 4.88 × 10−04 |
| 5146 | amoebiasis | 4 | 1.95 × 10−03 |
| 4670 | leukocyte transendothelial migration | 4 | 2.31 × 10−03 |
| 4932 | nonalcoholic fatty liver disease (NAFLD) | 4 | 5.60 × 10−03 |
| 5010 | Alzheimer’s disease | 4 | 7.58 × 10−03 |
| 5412 | arrhythmogenic right ventricular cardiomyopathy (ARVC) | 3 | 8.27 × 10−03 |
| 5203 | viral carcinogenesis | 4 | 8.27 × 10−03 |
| 5016 | Huntington’s disease | 4 | 8.27 × 10−03 |
| 4510 | focal adhesion | 4 | 1.16 × 10−02 |
| 4810 | regulation of actin cytoskeleton | 4 | 1.20 × 10−02 |
| 5322 | systemic lupus erythematosus | 3 | 1.35 × 10−02 |
| 5166 | HTLV-I infection | 4 | 2.08 × 10−02 |
| 4530 | tight junction | 3 | 2.84 × 10−02 |